地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：18771997407
传真：18327026838
邮箱：sales@amyjet.com
艾美捷科技有限公司代理Mimotopes公司多肽及多肽合成相关产品。Mimotopes公司位于澳大利亚，可以提供2000余种多肽，100余种药物及化妆品肽，1000余种各类氨基酸及多肽合成用试剂。
Mimotopes公司的主要产品类别：
（1）多肽（Peptides）
库存普通多肽（Catalogue Peptides）
化妆品肽（Cosmetic Peptides）
药物肽（Pharmaceutical Peptides）
肽库（Off-the-Shelf Library）
（2）氨基酸（Amino Acids）
Z Amino Acids
Unusual Amino Acids
N methyl Amino Acids
Fmoc Amino Acids
Common Amino Acids
Boc amino acids
AA attached_to_2-Chlorotrityl_Resin
AA attached_to_Wang_Resin
（3）多肽合成试剂（Peptides Synthesis Reagents）
Coupling Reagents
Amino Alcohols
General Reagents
Linkers
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
艾美捷科技特约代理Ellastin Products Company公司产品。Ellastin Products Company成立30余年，产品不多但是获得了许多客户的青睐，这些客户遍布于高校，研究机构，医学中心等。
Elastin Products Company, Inc. has been manufacturing quality biochemicals for 30 years. Providing research products to many pharmaceutical companies, universities, and researchers. Our quality in products have been estabilished for many years through the publishing of papers using EPC as the source. Thank you for the continued interest in our products.
ELASTIN PRODUCTS COMPANY的主要产品包括：
Polyclonal Antibody to Human Lung Tryptase IgG purified
Polyclonal Antibody to Proteinase 3-IgG purified
Polyclonal Antibody to Porcine Pancreas Elastase
Polyclonal Antibody to Human Myeloperoxidase
Monoclonal Antibody to Bovine Ligamentum Nuchae Elastin
Human Sputum Leucocyte Myeloperoxidase
Elastin Soluble
Lipase
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Elastin Products Company"> Elastin Products Company
Chondrex 公司成立于1996年，位于美国的华盛顿州，致力于为全球客户生产高品质的纯化的胶原蛋白、针对胶原蛋白的抗体及ELISA试剂盒产品。凭借Chondrex公司在炎症、胞外基质、结缔组织和免疫学方面的经验，该公司能为风湿性关节炎方面的研究者提供有力工具。
Chondrex, Inc. was founded in 1996 to provide high quality research reagents with unparalleled customer support. For over 20 years, Chondrex has been developing and manufacturing products such as highly purified collagen, anti-collagen monoclonal antibodies and a multitude of ELISA kits that provide researchers with the tools necessary to study the pathogenesis of and screen potential therapeutics for rheumatoid arthritis (RA). Through this experience, the scientists at Chondrex have established themselves as experts in inflammation, connective tissue, extracellular matrix, and immunology based research.
（1）过敏反应/变态反应
变态反应性IgE 单克隆抗体、小鼠抗-OVAIgE 抗体的配套测定试剂、小鼠总IgE(IgEa 和IgEb)的配套检测试剂、小鼠血清抗-OVA IgE 抗体的配套测定试剂、小鼠抗-OVA IgG 的配套测定试剂
（2）关节炎
制造CAIA(胶原抗体引起的关节炎)模型用的单克隆抗体合剂、用于CIA 和其他研究的胶原(I, II, IX 和XI 型)、免疫接种等级、佐剂、ELISA(酶联免疫吸附试验)等级、T-细胞增殖试验等级、II 型胶原的溴化氰(Cyanogen Bromide-CB)裂解的多肽片段、抗-胶原抗体的配套测定试剂、小鼠抗-I 型和II 型胶原IgG 的配套测定试剂、大鼠抗-I 型和II 型胶原IgG 的配套测定试剂、人/猿猴抗-I 型和II 型胶原IgG 的配套测定试、人/猿猴抗-I 型和II 型胶原IgA 的配套测定试剂、小鼠抗-胶原IgG 亚型的配套测定试剂
（3）研究结缔组织的试剂
人I 型天然胶原的配套检测试剂、II 型天然胶原的配套检测试剂、胶原半定量的配套测定试剂(Sirius Red/Fast Green 染色配套试剂)、胶原免疫染色的配套试剂、II 型胶原染色配套试剂、IX 型胶原染色配套试剂、抗-I 型,II 型和IX 型胶原的单克隆抗体
（4）胶原酶测定
MMP-8 (2型胶原酶)的配套测定试剂、MMP-13 (3型胶原酶)抑制剂的配套测定试剂、荧光标记的胶原(FITC-Labeled Collagen)、重组的人MMP-8和MMP-13
（5）肾炎
诱发大鼠肾炎的单克隆抗体、大鼠尿蛋白的配套测定试剂
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Chondrex"> Chondrex
Chemicell公司位于德国柏林，该公司主要进行创新的以纳米级磁珠为基础的生物分离、基因转染&检测系统开发和生产工作。开发的重点在于设计以客户为导向特别兼容了实验室自动化的即用型试剂盒。
chemicell develops and produces innovative bioseparation- gene transfection and detection systems based on magnetic nano- and microparticles. Focus of our product development is to design high quality customer-oriented "ready-to use" kits with special orientation towards the compatibility for labor automatisation. It is chemicell's policy to be open for cooperations with other companies or scientific institutes to maximize the chances and opportunities that evolve from the rapid development of biotechnological procedures and to distribute innovative new products.
主要产品包括：
Magnetofection™
Biomagnetic Separation
Magnetic Microparticles
Magnetic-Fluorescent Microparticles
Magnetic Nanoparticles
Magnetic-Fluorescent Nanoparticles
Microspheres-Non-Magnetic
Silica Microspheres-Non-Magnetic
Silica Fluorescent Microspheres-Non-Magnetic
Magnetic Separators
DNA / RNA Purification
PEG derivates
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Chemicell"> Chemicell
艾美捷科技代理rPeptide品牌全系列重组蛋白及多肽产品。
rPeptide公司提供高质量的肽、试剂、蛋白质、抗体等，专注于老年痴呆症和帕金森病的研究。rPeptide专有的平台载体技术能够在大肠杆菌中以可溶性肽/蛋白质的形式重组表达困难的肽/蛋白质。rPeptide还提供大量的β-淀粉样蛋白、taus、突触核蛋白、钙调素、定制产品等。
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
rPeptide产品详情请见艾美捷科技丁香通商城：
https://vicbio.biomart.cn/supply/c_282851.htm
<| Beta Amyloid 7E7 50ug and Beta Amyloid (1-40)NH4OH .25mg | BA-1101-1 | 50ug |
| Beta Amyloid 7E7 100ug and Beta Amyloid (1-40)NH4OH .5mg | BA-1101-2 | 100ug |
| Beta Amyloid 7E7 .5mg and Beta Amyloid (1-40)NH4OH .5mg | BA-1101-3 | 0.5mg |
| Beta Amyloid 7E7 1.0mg and Beta Amyloid (1-40)NH4OH 1.0mg | BA-1101-4 | 1.0mg |
| Beta Amyloid 7E7 50ug and Beta Amyloid (1-42)NH4OH .25mg | BA-1102-1 | 50ug |
| Beta Amyloid 7E7 100ug and Beta Amyloid (1-42)NH4OH .5mg | BA-1102-2 | 100ug |
| Beta Amyloid 7E7 .5mg and Beta Amyloid (1-42)NH4OH .5mg | BA-1102-3 | 0.5mg |
| Beta Amyloid 7E7 1.0mg and Beta Amyloid (1-42)NH4OH 1.0mg | BA-1102-4 | 1.0mg |
| Beta Amyloid 6C2 50ug and Beta Amyloid (1-40)NH4OH .25mg | BA-2201-1 | 50ug |
| Beta Amyloid 6C2 100ug and Beta Amyloid (1-40)NH4OH .5mg | BA-2201-2 | 100ug |
| Beta Amyloid 6C2 .5mg and Beta Amyloid (1-40)NH4OH .5mg | BA-2201-3 | 0.5mg |
| Beta Amyloid 6C2 1.0mg and Beta Amyloid (1-40)NH4OH 1.0mg | BA-2201-4 | 1.0mg |
| Beta Amyloid 6C2 50ug and Beta Amyloid (1-42)NH4OH .25mg | BA-2202-1 | 50ug |
| Beta-Amyloid 6C2, 100ug and Beta Amyloid (1-42) NH4OH 0.5mg | BA-2202-2 | 100ug |
| Beta Amyloid 6C2 .5mg and Beta Amyloid (1-42)NH4OH .5mg | BA-2202-3 | 0.5mg |
| Beta Amyloid 6C2 1.0mg and Beta Amyloid (1-42)NH4OH 1.0mg | BA-2202-4 | 1.0mg |
| Beta Amyloid (1-40) Aggregation Kit | A-1180-02 | 1 x .25mg |
| Beta Amyloid (1-40) Aggregation Kit | A-1180-1 | 1 x 0.5mg |
| Beta Amyloid (1-40) Aggregation Kit | A-1180-2 | 1 x 1.0mg |
| Beta Amyloid (1-42) Aggregation Kit | A-1170-02 | 1 x .25 mg |
| Beta Amyloid (1-42) Aggregation Kit | A-1170-1 | 1 x 0.5 mg |
| Beta Amyloid (1-42) Aggregation Kit | A-1170-2 | 1 x 1.0 mg |
| Beta-Amyloid (1-40), Mouse, Rat | A-1007-1 | 0.5 mg |
| Beta-Amyloid (1-40), Starter Kit | A-1150-1 | 5 x 0.5 mg |
| Beta-Amyloid (1-40), Starter Kit | A-1150-2 | 5 x 1.0 mg |
| Beta-Amyloid (1-40), Ultra Pure, HCl | A-1156-1 | 0.5 mg |
| Beta-Amyloid (1-40), Ultra Pure, HCl | A-1156-2 | 1.0 mg |
| Beta-Amyloid (1-40), Ultra Pure, HFIP | A-1153-1 | 0.5 mg |
| Beta-Amyloid (1-40), Ultra Pure, HFIP | A-1153-2 | 1.0 mg |
| Beta-Amyloid (1-40), Ultra Pure, NaOH | A-1155-1 | 0.5 mg |
| Beta-Amyloid (1-40), Ultra Pure, NaOH | A-1155-2 | 1.0 mg |
| Beta-Amyloid (1-40), Ultra Pure, TFA | A-1001-1 | 0.5 mg |
| Beta-Amyloid (1-40), Ultra Pure, TFA | A-1001-2 | 1.0 mg |
| Beta-Amyloid (1-40), Ultra-Pure, Ammonium Hydroxide | A-1157-02 | 250 ug |
| Beta-Amyloid (1-40), Ultra-Pure, Ammonium Hydroxide | A-1157-1 | 0.5 mg |
| Beta-Amyloid (1-40), Ultra-Pure, Ammonium Hydroxide | A-1157-2 | 1 mg |
| Beta-Amyloid (1-40, D23N) | A-1013-1 | 100 µg |
| Beta-Amyloid (1-40, D23N) | A-1013-2 | 1.0 mg |
| Beta-Amyloid (1-40, F4W) | A-1011-1 | 100 µg |
| Beta-Amyloid (1-11) | A-1051-1 | 1.0 mg |
| Beta-Amyloid (1-11) | A-1051-2 | 5.0 mg |
| Beta-Amyloid (1-16) | A-1052-1 | 1.0 mg |
| Beta-Amyloid (1-16) | A-1052-2 | 5.0 mg |
| Beta-Amyloid (1-28) | A-1053-1 | 0.5 mg |
| Beta-Amyloid (1-28) | A-1053-2 | 1.0 mg |
| Beta-Amyloid (1-38) | A-1078-1 | 0.5 mg |
| Beta-Amyloid (1-38) | A-1078-2 | 1.0 mg |
| Beta-Amyloid (11-22) | A-1055-1 | 1.0 mg |
| Beta-Amyloid (11-22) | A-1055-2 | 5.0 mg |
| Beta-Amyloid (11-40) | A-1061-2 | 1.0 mg |
| Beta-Amyloid (11-40), Mouse, Rat | A-1062-01 | 0.1 mg |
| Beta-Amyloid (11-40), Mouse, Rat | A-1062-1 | 0.5 mg |
| Beta-Amyloid (11-42) | A-1063-2 | 1.0 mg |
| Beta-Amyloid (12-28) | A-1056-1 | 0.5 mg |
| Beta-Amyloid (12-28) | A-1056-2 | 1.0 mg |
| Beta-Amyloid (17-40) | A-1057-1 | 0.5 mg |
| Beta-Amyloid (17-40) | A-1057-2 | 1.0 mg |
| Beta-Amyloid (17-42) | A-1058-1 | 0.5 mg |
| Beta-Amyloid (17-42) | A-1058-2 | 1.0 mg |
| Beta-Amyloid (22-35) | A-1059-1 | 1.0 mg |
| Beta-Amyloid (22-35) | A-1059-2 | 5.0 mg |
| Beta-Amyloid (25-35) | A-1060-1 | 1.0 mg |
| Beta-Amyloid (25-35) | A-1060-2 | 5.0 mg |
| 13C Beta-Amyloid (1-40), Uniformly labeled | A-1105-1 | 0.5 mg |
| 13C Beta-Amyloid (1-40), Uniformly labeled | A-1105-2 | 1.0 mg |
| 13C Beta-Amyloid (1-42), Uniformly labeled | A-1106-1 | 0.5 mg |
| 13C Beta-Amyloid (1-42), Uniformly labeled | A-1106-2 | 1.0 mg |
| 13C, 15N Beta-Amyloid (1-40), Uniformly labeled | A-1103-01 | 0.1 mg |
| 13C, 15N Beta-Amyloid (1-40), Uniformly labeled | A-1103-1 | 0.5 mg |
| 13C, 15N Beta-Amyloid (1-40), Uniformly labeled | A-1103-2 | 1.0 mg |
| 13C, 15N Beta-Amyloid (1-42), Uniformly labeled | A-1104-1 | 0.5 mg |
| 13C, 15N Beta-Amyloid (1-42), Uniformly labeled | A-1104-2 | 1.0 mg |
| 13C, 15N Beta-Amyloid (1-43), Uniformly labeled | A-1108-1 | 0.5 mg |
| 13C, 15N Beta-Amyloid (1-43), Uniformly labeled | A-1108-2 | 1.0 mg |
| 13C, Beta-Amyloid (1-43), Uniformly labeled | A-1109-1 | 0.5 mg |
| 13C, Beta-Amyloid (1-43), Uniformly labeled | A-1109-2 | 1.0 mg |
| 15N Beta-Amyloid (1-38), U. label | A-1147-1 | 0.1 mg |
| 15N Beta-Amyloid (1-38), U. label | A-1147-2 | 1.0 mg |
| 15N Beta-Amyloid (1-40), Rat, U. labeled | A-1131-1 | 0.5 mg |
| 15N Beta-Amyloid (1-40), Uniformly labeled | A-1101-1 | 0.1 mg |
| 15N Beta-Amyloid (1-40), Uniformly labeled | A-1101-2 | 1.0 mg |
| 15N Beta-Amyloid (1-42), Rat, U. labeled | A-1134-1 | 0.1 mg |
| 15N Beta-Amyloid (1-42), Rat, U. labeled | A-1134-2 | 1.0 mg |
| 15N Beta-Amyloid (1-42), Uniformly labeled | A-1102-1 | 0.1 mg |
| 15N Beta-Amyloid (1-42), Uniformly labeled | A-1102-2 | 1.0 mg |
| 15N Beta-Amyloid (1-43), Uniformly labeled | A-1107-1 | 1.0 mg |
| 15N Beta-Amyloid (1-46), U. label | A-1179-1 | 0.1 mg |
| 15N Beta-Amyloid (1-46), U. label | A-1179-2 | 0.5 mg |
| 15N Beta-Amyloid (11-40), Rat, U. label | A-1140-1 | 1.0 mg |
| 15N Beta-Amyloid (11-40), Uniformly labeled | A-1137-1 | 1.0 mg |
| 15N Beta-Amyloid (11-42), U. label | A-1120-2 | 1.0 mg |
| Biotin-Beta-Amyloid (1-40) | A-1111-01 | 0.1 mg |
| Biotin-Beta-Amyloid (1-40) | A-1111-2 | 1.0 mg |
| Biotin-Beta-Amyloid (1-42) | A-1117-1 | 0.5 mg |
| Biotin-LC-Beta-Amyloid (1-40) | A-1112-1 | 0.5 mg |
| Biotin-LC-Beta-Amyloid (1-40) | A-1112-2 | 1.0 mg |
| Biotin-LC-Beta-Amyloid (1-42) | A-1118-1 | 0.5 mg |
| Fluorescein-Beta-Amyloid (1-40) | A-1113-1 | 0.5 mg |
| Fluorescein-Beta-Amyloid (1-42) | A-1119-1 | 0.5 mg |
| Calmodulin, Porcine, Biotinylated | C-1002-1 | 100 µg |
| Calmodulin, Porcine, Fluorescein | C-1003-1 | 100 µg |
| Calmodulin, Porcine, Rhodamine | C-1004-1 | 100 µg |
| Calmodulin, Wheat (Triticum aestivum), Biotinylated | C-1008-1 | 50 µg |
| Calmodulin, Wheat (Triticum aestivum), Fluorescein | C-1009-1 | 50 µg |
| Calmodulin, Wheat (Triticum aestivum), Rhodamine | C-1010-1 | 50 µg |
| 15N Tau-441 (2N4R) Uniform Labeled | T-1101-1 | 50ug |
| 15N Tau-441 (2N4R) Uniform Labeled | T-1101-2 | 100ug |
| Tau Protein Ladder, of all 6 isoforms | T-1007-1 | 50 µl |
| Tau Protein Ladder, of all 6 isoforms | T-1007-2 | 100 µl |
| Tau Starter Kit | T-1170-1 | 50 µg |
| Tau Starter Kit | T-1170-2 | 100 µg |
| Tau-352, (0N3R) | T-1006-1 | 50 µg |
| Tau-352, (0N3R) | T-1006-2 | 100 µg |
| Tau-381, (1N3R) | T-1004-1 | 50 µg |
| Tau-381, (1N3R) | T-1004-2 | 100 µg |
| Tau-383, (0N4R) | T-1005-1 | 50 µg |
| Tau-383, (0N4R) | T-1005-2 | 100 µg |
| Tau-410, (2N3R) | T-1002-1 | 50 µg |
| Tau-410, (2N3R) | T-1002-2 | 100 µg |
| Tau-412, (1N4R) | T-1003-1 | 50 µg |
| Tau-412, (1N4R) | T-1003-2 | 100 µg |
| Tau-441, (2N4R) | T-1001-1 | 50 µg |
| Tau-441, (2N4R) | T-1001-2 | 100 µg |
| Tau-441, (2N4R), G272V mutant | T-1013-1 | 50 µg |
| Tau-441, (2N4R), P301L mutant | T-1014-1 | 50 µg |
| Tau-441, (2N4R), R406W mutant | T-1011-1 | 50 µg |
| Tau-441, (2N4R), V248L mutant | T-1015-1 | 50 µg |
| Tau-441, (2N4R), V337M mutant | T-1012-1 | 50 µg |
| Tubulin, Porcine | T-1201-1 | 1.0 mg |
| Latherin | L-1001-1 | 50ug |
| Latherin | L-1001-2 | 100ug |
| Latherin | L-1001-3 | 0.5mg |
| 15N, Alpha-Synuclein, Uniform Label | S-1004-1 | 0.5 mg |
| 15N, Alpha-Synuclein, Uniform Label | S-1004-2 | 1.0 mg |
| 15N, Beta-Synuclein, Uniform Label | S-1102-1 | .5mg |
| 15N, Beta-Synuclein, Uniform Label | S-1102-2 | 1.0mg |
| Alpha Synuclein Mouse | S-1010-1 | 0.5mg |
| Alpha Synuclein Mouse | S-1010-2 | 1.0mg |
| Alpha-Synuclein | S-1001-1 | 0.5 mg |
| Alpha-Synuclein | S-1001-2 | 1.0 mg |
| Alpha-Synuclein, 1-60 | S-1011-1 | 0.5 mg |
| Alpha-Synuclein, 1-95 | S-1012-1 | 0.5 mg |
| Alpha-Synuclein, 112 (NACP 112) | S-1016-1 | 0.5 mg |
| Alpha-Synuclein, 61-140 | S-1013-1 | 0.5 mg |
| Alpha-Synuclein, 96-140 | S-1014-1 | 0.5 mg |
| Alpha-Synuclein, A30P mutant | S-1005-1 | 0.5 mg |
| Alpha-Synuclein, A30P mutant | S-1005-2 | 1.0 mg |
| Alpha-Synuclein, A30P, A53T mutant | S-1006-1 | 0.5 mg |
| Alpha-Synuclein, A30P, A53T mutant | S-1006-2 | 1.0 mg |
| Alpha-Synuclein, A53T mutant | S-1002-1 | 0.5 mg |
| Alpha-Synuclein, A53T mutant | S-1002-2 | 1.0 mg |
| Alpha-Synuclein, Delta NAC | S-1015-1 | 0.5 mg |
| Alpha-Synuclein, E46K mutant | S-1008-1 | 0.5 mg |
| Alpha-Synuclein, E46K mutant | S-1008-2 | 1.0 mg |
| Beta-Synuclein | S-1003-1 | 0.5 mg |
| Beta-Synuclein | S-1003-2 | 1.0 mg |
| Gamma-Synuclein | S-1007-1 | 0.5 mg |
| Gamma-Synuclein | S-1007-2 | 1.0 mg |
| Gamma-Synuclein, Mouse | S-1009-1 | 0.5 mg |
| Gamma-Synuclein, Mouse | S-1009-2 | 1.0 mg |
| APP 669-711, HCl | AP-1156-1 | 0.5mg |
| APP 669-711, HCl | AP-1156-2 | 1.0mg |
| APP 669-711, HFIP | AP-1153-1 | 0.5mg |
| APP 669-711, HFIP | AP-1153-2 | 1.0mg |
| APP 669-711, N15 Uniformly Labelled | AP-1101-1 | 0.5mg |
| APP 669-711, N15 Uniformly Labelled | AP-1101-2 | 1.0mg |
| APP 669-711, NaOH | AP-1155-1 | 0.5mg |
| APP 669-711, NaOH | AP-1155-2 | 1.0mg |
| APP 669-711, NH4OH | AP-1157-1 | 0.5mg |
| APP 669-711, NH4OH | AP-1157-2 | 1.0mg |
| APP 669-711, TFA | AP-1001-1 | 0.5mg |
| APP 669-711, TFA | AP-1001-2 | 1.0mg |
| Apolipoprotein E, Human Plasma, VLDL | A-2001-1 | 50 µg |
| Alpha 1 Antichymotrypsin | A-2002-1 | 100 µg |
| Alpha 1 Antitrypsin | A-2003-1 | 1.0 mg |
| Alpha 2 Macroglobulin | A-2004-1 | 1.0 mg |
| Chymotrypsin | A-2005-1 | 100 µg |
| Haptoglobin | A-2006-1 | 1.0 mg |
| Myeloperoxidase | A-2007-1 | 100 µg |
| Plasmin | A-2008-1 | 1.0 mg |
| Plasminogen | A-2009-1 | 1.0 mg |
| Transferrin | A-2010-1 | 100 mg |
| Calmodulin, Porcine | C-1001-1 | 1 mg |
| Calmodulin, Wheat (Triticum aestivum) & Porcine | C-1006-1 | 200 µl |
| Calmodulin-SH, Wheat (Triticum aestivum) | C-1007-1 | 250 µg |
| Calmodulin-SH, Wheat (Triticum aestivum), Immobilized | C-1011-1 | 200 µl |
| Alpha Synuclein 10C3 Antibody | SA-3001-1 | 100ug |
| Alpha Synuclein 10C3 Antibody | SA-3001-2 | 1mg |
| Alpha Synuclein 10D2 Antibody | SA-3003-1 | 100ug |
| Alpha Synuclein 10D2 Antibody | SA-3003-2 | 1mg |
| Alpha Synuclein 5G4 Antibody | SA-3002-1 | 100ug |
| Alpha Synuclein 5G4 Antibody | SA-3002-2 | 1mg |
| Alpha Synuclein pAB 63 Antibody | SA-3004-1 | 100ul |
| Alpha Synuclein pAB 63 Antibody | SA-3004-2 | 1ml |
| Tau 3G3 | TA-3012-1 | 100ug |
| Tau 3G3 | TA-3012-2 | 1 mg |
| Tau 4C10 | TA-3011-1 | 100ug |
| Tau 4C10 | TA-3011-2 | 1mg |
| Tau 9D8 Antibody | TA-3010-1 | 100ug |
| Tau 9D8 Antibody | TA-3010-2 | 1mg |
| Tau total 12C2 | TA-3015-1 | 100ug |
| Tau total 12C2 | TA-3015-2 | 1mg |
| Tau total 18B5 | TA-3016-1 | 100ug |
| Tau total 18B5 | TA-3016-2 | 1 mg |
| Tau total 4B5 | TA-3013-1 | 100ug |
| Tau total 4B5 | TA-3013-2 | 1mg |
| Tau total 7E5 | TA-3017-1 | 100ug |
| Tau total 7E5 | TA-3017-2 | 1mg |
| Tau total 8F10 | TA-3014-1 | 100ug |
| Tau total 8F10 | TA-3014-2 | 1 mg |
| Tau total pAB 64 | TA-3020-1 | 100ul |
| Tau total pAB 64 | TA-3020-2 | 1 mg |
| Tau-10D3 Antibody | TA-3004-1 | 100ug |
| Tau-10D3 Antibody | TA-3004-2 | 1mg |
| Tau-10F8 Antibody | TA-3007-1 | 100ug |
| Tau-10F8 Antibody | TA-3007-2 | 1mg |
| Tau-1A6 Antibody | TA-2001-1 | 50ug |
| Tau-1A6 Antibody | TA-2001-2 | 100ug |
| Tau-1A6 Antibody | TA-2001-3 | 1.0mg |
| Tau-1A6 Antibody Kit | TA-1101-1 | 50ug |
| Tau-1A6 Antibody Kit | TA-1101-2 | 100ug |
| Tau-1A6 Antibody Kit TA-2002 | TA-1102-1 | 50ug |
| Tau-1A6 Antibody Kit TA-2002 | TA-1102-2 | 100ug |
| Tau-1A6 Antibody Kit TA-2004 | TA-1104-1 | 50ug |
| Tau-1A6 Antibody Kit TA-2004 | TA-1104-2 | 100ug |
| Tau-1A6 Antibody Kit TA-2005 | TA-1105-1 | 50ug |
| Tau-1A6 Antibody Kit TA-2005 | TA-1105-2 | 100ug |
| Tau-1A6 Antibody Kit TA-2006 | TA-1106-1 | 50ug |
| Tau-1A6 Antibody Kit TA-2006 | TA-1106-2 | 100ug |
| Tau-1A6 Antibody Kit TA-2007 | TA-1107-1 | 50ug |
| Tau-1A6 Antibody Kit TA-2007 | TA-1107-2 | 100ug |
| Tau-1A6 Antibody Kit TA-2008 | TA-1108-1 | 50ug |
| Tau-1A6 Antibody Kit TA-2008 | TA-1108-2 | 100ug |
| Tau-1E7 Antibody | TA-3001-1 | 100ug |
| Tau-1E7 Antibody | TA-3001-2 | 1mg |
| Tau-1F3 Antibody | TA-3005-1 | 100ug |
| Tau-1F3 Antibody | TA-3005-2 | 1mg |
| Tau-2B11 Antibody | TA-3008-1 | 100ug |
| Tau-2B11 Antibody | TA-3008-2 | 1mg |
| Tau-4G11 Antibody | TA-1001-1 | 50ug |
| Tau-4G11 Antibody | TA-1001-2 | 100ug |
| Tau-4G11 Antibody | TA-1001-3 | 1.0mg |
| Tau-4G11 Antibody Kit | TA-1111-1 | 50ug |
| Tau-4G11 Antibody Kit | TA-1111-2 | 100ug |
| Tau-4G11 Antibody Kit TA-1003 | TA-1113-1 | 50ug |
| Tau-4G11 Antibody Kit TA-1003 | TA-1113-2 | 100ug |
| Tau-4G11 Antibody Kit TA-1004 | TA-1114-1 | 50ug |
| Tau-4G11 Antibody Kit TA-1004 | TA-1114-2 | 100ug |
| Tau-4G11 Antibody Kit TA-1005 | TA-1115-1 | 50ug |
| Tau-4G11 Antibody Kit TA-1005 | TA-1115-2 | 100ug |
| Tau-4G11 Antibody Kit TA-1006 | TA-1116-1 | 50ug |
| Tau-4G11 Antibody Kit TA-1006 | TA-1116-2 | 100ug |
| Tau-4G11 Antibody Kit TA-1007 | TA-1117-1 | 50ug |
| Tau-4G11 Antibody Kit TA-1007 | TA-1117-2 | 100ug |
| Tau-4G11 Antibody Kit TA-1008 | TA-1118-1 | 50ug |
| Tau-4G11 Antibody Kit TA-1008 | TA-1118-2 | 100ug |
| Tau-4G11 Antibody Kit TA-1009 | TA-1119-1 | 50ug |
| Tau-4G11 Antibody Kit TA-1009 | TA-1119-2 | 100ug |
| Tau-5G7 Antibody | TA-3009-1 | 100ug |
| Tau-5G7 Antibody | TA-3009-2 | 1mg |
| Tau-8B11 Antibody | TA-3002-1 | 100ug |
| Tau-8B11 Antibody | TA-3002-2 | 1mg |
| Tau-8D2 Antibody | TA-3003-1 | 100ug |
| Tau-8D2 Antibody | TA-3003-2 | 1mg |
| Tau-9C8 Antibody | TA-3006-1 | 100ug |
| Tau-9C8 Antibody | TA-3006-2 | 1mg |
| Tau-E2+E3 9E11 | TA-3019-1 | 100ug |
| Tau-E2+E3 9E11 | TA-3019-2 | 1mg |
| Tau-E3 2B6 | TA-3018-1 | 100ug |
| Tau-E3 2B6 | TA-3018-2 | 1mg |
| AK-7 | N-3003-1 | 5 mg |
| AK-7 | N-3003-2 | 25 mg |
| ANA-12 | N-3031-1 | 5 mg |
| ANA-12 | N-3031-2 | 25 mg |
| Apomorphine HCI Hemihydrate | N-3027-1 | 100 mg |
| Apomorphine HCI Hemihydrate | N-3027-2 | 500 mg |
| Benztropine Mesylate | N-3012-1 | 1 gm |
| Bexarotene | N-3032-1 | 10 mg |
| Bexarotene | N-3032-2 | 50 mg |
| C-646 | N-3002-1 | 5 mg |
| C-646 | N-3002-2 | 25 mg |
| C16 | N-3030-1 | 5 mg |
| C16 | N-3030-2 | 25 mg |
| Candesartan | N-2049-1 | 20mg |
| Candesartan | N-2049-2 | 100mg |
| Celastrol | N-2187-1 | 10mg |
| Celastrol | N-2187-2 | 50mg |
| CNEE | N-1062-1 | 5mg |
| CNEE | N-1062-2 | 25mg |
| CTPB | N-3001-1 | 5 mg |
| CTPB | N-3001-2 | 25 mg |
| DAPT | N-3018-1 | 5 mg |
| DAPT | N-3018-2 | 25 mg |
| Deoxymannojirimycin HCl | N-2798-1 | 1mg |
| Deoxymannojirimycin HCl | N-2798-2 | 5mg |
| Diazoxide | N-3026-1 | 100 mg |
| Diazoxide | N-3026-2 | 500 mg |
| DMOG | MC-2371-1 | 10mg |
| DMOG | MC-2371-2 | 50mg |
| DU-14 | N-1187-1 | 5mg |
| DU-14 | N-1187-2 | 25mg |
| Edaravone | N-3034-1 | 1 gm |
| Edaravone | N-3034-2 | 5 gm |
| Entacapone | N-2025-1 | 10mg |
| Entacapone | N-2025-2 | 50mg |
| Epoxycholesterol | N-1330-1 | 1mg |
| Epoxycholesterol | N-1330-2 | 5mg |
| Ferrostatin-1 | N-1380-1 | 5mg |
| Ferrostatin-1 | N-1380-2 | 25mg |
| Fingolimod | N-3025-1 | 5 mg |
| Fingolimod | N-3025-2 | 25 mg |
| FK-506 | N-3024-1 | 20 mg |
| FK-506 | N-3024-2 | 100 mg |
| FPS-ZM1 | N-1635-1 | 5mg |
| FPS-ZM1 | N-1635-2 | 25mg |
| Gabapentin lactam | N-2535-1 | 50mg |
| Gabapentin lactam | N-2535-2 | 250mg |
| Imatinib Mesylate | N-3020-1 | 20 mg |
| Imatinib Mesylate | N-3020-2 | 100 mg |
| ISO-1 | N-3017-1 | 10 mg |
| ISO-1 | N-3017-2 | 50 mg |
| ISRIB | N-1539-1 | 5mg |
| ISRIB | N-1539-2 | 25mg |
| ISX9 | N-3010-1 | 5 mg |
| ISX9 | N-3010-2 | 25 mg |
| IU1 | N-1197-1 | 10mg |
| IU1 | N-1197-2 | 50mg |
| LM11A-31 2HCI | N-3005-1 | 5 mg |
| LM11A-31 2HCI | N-3005-2 | 25 mg |
| LM22A-4 | N-3006-1 | 10 mg |
| LM22A-4 | N-3006-2 | 50 mg |
| Minocyline HCI | N-3013-1 | 50 mg |
| Minocyline HCI | N-3013-2 | 250 mg |
| Mithramycin A | N-2085-1 | 1mg |
| Mithramycin A | N-2085-2 | 5mg |
| Mitoquinone | N-1363-1 | 5mg |
| Mitoquinone | N-1363-2 | 25mg |
| Montelukast Sodium | N-3028-1 | 50 mg |
| Montelukast Sodium | N-3028-2 | 250 mg |
| Mycophenolate mofetil | N-2086-1 | 50mg |
| Mycophenolate mofetil | N-2086-2 | 250mg |
| Neurodazine | N-3014-1 | 5 mg |
| Neurodazine | N-3014-2 | 25 mg |
| Neuropathiazol | N-3015-1 | 5 mg |
| Neuropathiazol | N-3015-2 | 25 mg |
| Noopept | N-2682-1 | 10mg |
| Noopept | N-2682-2 | 50mg |
| P7C3 | N-3004-1 | 5 mg |
| P7C3 | N-3004-2 | 25 mg |
| Phenylbutyrate Na | MC-1118-1 | 1gm |
| Phenylbutyrate Na | MC-1118-2 | 5gm |
| Pinacidil | N-2856-1 | 10mg |
| Pinacidil | N-2856-2 | 50mg |
| Prostratin | N-3011-1 | 1 mg |
| Prostratin | N-3011-2 | 5 mg |
| Rapamycin | N-3022-1 | 20 mg |
| Rapamycin | N-3022-2 | 100 mg |
| Resveratrol | N-3019-1 | 100 mg |
| Resveratrol | N-3019-2 | 500 mg |
| Roscovitine | N-1332-1 | 5mg |
| Roscovitine | N-1332-2 | 25mg |
| Salirasib | N-1461-1 | 5mg |
| Salirasib | N-1461-2 | 25mg |
| SB-225022 | N-3016-1 | 5 mg |
| SB-225022 | N-3016-2 | 25 mg |
| Tianeptine | N-3008-1 | 10 mg |
| Tianeptine | N-3008-2 | 50 mg |
| Tolcapone | N-3007-1 | 10 mg |
| Tolcapone | N-3007-2 | 50 mg |
| TRO 19622 | N-3029-1 | 5 mg |
| TRO 19622 | N-3029-2 | 25 mg |
| Vildagliptin | N-2887-1 | 20mg |
| Vildagliptin | N-2887-2 | 100mg |
| Vorinostat | N-3021-1 | 50 mg |
| Vorinostat | N-3021-2 | 250 mg |
| Zileuton | N-3023-1 | 10 mg |
| Zileuton | N-3023-2 | 50 mg |
| Zolmitriptan | N-3033-1 | 10 mg |
| Zolmitriptan | N-3033-2 | 50 mg |
<艾美捷科技有限公司授权代理Katchem公司全系列产品。
产品详情请见艾美捷科技丁香通商铺或直接咨询客服人员。
https://vicbio.biomart.cn/supply/c_307368.htm
Katchem公司，位于捷克共和国Prague，是一家主要生产硼化学产品的公司，其产品主要包括：硼酸盐和碳硼酸盐簇、十硼烷（14）簇、碳硼烷、COSANes、金属硼氢化物、硼砂及其衍生物、硼烷-路易斯碱配合物、硼酸和酯、BNCT用化合物、非硼化合物、二氨基甲酸盐和催化系统等。
【产品应用场景1】
中子治疗，硼中子俘获治疗（Boron Neutron Capture Therapy，简称BNCT）。
BNCT的原理是利用发生在肿瘤细胞内的核反应摧毁癌细胞，由于同时需要中子源和B，因此，是一种二元化治疗肿瘤的新方法。BNCT的基本过程分为两部分：首先在肿瘤细胞内聚积足够量的稳定性核素B，即将一种含B的化合物引入患者体内，这种化合物与肿瘤细胞有很强的亲和力，进入体内后，迅速聚集于肿瘤细胞内，而在其它正常组织中分布很少；然后再用中子束照射肿瘤部位，使中子与肿瘤细胞内聚集的B发生B（n,α）Li核反应，B俘获中子后，形成同位素B，B迅速分裂为重粒子Li和α，肿瘤细胞被α射线和Li照射而死亡。适用于硼中子捕获治疗的含硼化合物应具备四个重要特性：对人体毒性低、对正常细胞的亲和性低、对癌细胞的亲和性高（最好可达正常细胞的3倍以上，且每克癌细胞分布的硼达到20微克以上）、能被人体迅速从正常细胞和血液移除。目前仅有两种含硼化合物应用在临床试验：Sodium Borocaptate (BSH)以及Boronophenylalanine(BPA)。
【产品应用场景2】
电池研发。
【热销产品】
【产品列表】
| 产品编码 | 产品名称 | CAS号 | 规格（g） |
| 410 | Sodium triborate dioxane | CAS [33220-35-8] | 1、5、10、25、50 |
| 458 | Cesium triborate | CAS [12007-45-3] | 1、5、10 |
| 564 | LIthium triborate dioxane | CAS [212697-88-6] | 1、5、10 |
| 315 | Triethylammonium decahydrodecaborate | CAS [12075-73-9] | 5、10、25、50、100 |
| 333 | Tetramethylammonium decahydrodecaborate | CAS [12073-87-9] | 5、10、25、50、100 |
| 493 | Sodium decahydrodecaborate | CAS [12294-20-1] | 5、10、25、50、100 |
| 459 | Ammonium decahydrodecaborate | CAS [12008-61-6] | 5、10、25、50、100 |
| 229 | Potassium decahydrodecaborate | CAS [12447-89-1] | 5、10、25、50、100 |
| 246 | Cesium decahydrodecaborate | CAS [12008-58-1] | 10、25、50、100 |
| 675 | Lithium decahydrodecaborate, trihydrate | CAS [64719-89-7 anhyd] | 5、10、25 |
| 812 | Calcium decahydrodecaborate, trihydrate | CAS [64719-84-2 anhyd] | 5、10、25 |
| 804 | Cesium decachlorodecaborate | CAS [12360-16-6] | 5、10、25、50 |
| 805 | Cesium decabromodecaborate | CAS [12356-10-4] | 5、10、25、50 |
| 803 | Cesium decaiododecaborate | CAS [88423-95-4] | 5、10、25、50 |
| 324 | Cesium tetradecahydroundecaborate | CAS [12008-72-9] | 5、10、25、50、100 |
| 453 | Triethylammonium tetradecahydroundecaborate | CAS [12106-44-4] | 5、10、25、50、100 |
| 614 | Potassium tetradecahydroundecaborate | CAS [52261-21-9] | 5、10、25、50、100 |
| 615 | Sodium tetradecahydroundecaborate | CAS [52261-23-1] | 5、10、25、50、100 |
| 372 | Trimethylammonium tetradecahydroundecaborate | CAS [12076-74-3] | 5、10、25、50、100 |
| 684 | Lithium tetradecahydroundecaborate, trihydrate | CAS [52261-22-0 anhyd.] | 1、5、10 |
| 815 | Calcium tetradecahydroundecaborate, dihydrate | 1、5、10 | |
| 290 | Triethylammonium dodecahydrododecaborate | CAS [12551-42-7] | 5、10、25、50、100、250、1000 |
| 316 | Cesium dodecahydrododecaborate | CAS [12008-75-2] | 5、10、25、50、100、250、1000 |
| 228 | Potassium dodecahydrododecaborate | CAS [12008-77-4] | 5、10、25、50、100、250、1000 |
| 257 | Sodium dodecahydrododecaborate | CAS [12008-78-5] | 5、10、25、50、100、250、1000 |
| 328 | Sodium dodecahydrododecaborate anhydrous, <0.1% water | CAS [12008-78-5] | 5、10、25、50、100、250 |
| 569 | Lithium dodecahydrododecaborate, tetrahydrate | CAS [1166383-94-3] | 5、10、25、50、100、250、1000 |
| 445 | Magnesium dodecahydrododecaborate, tetrahydrate | CAS [53572-04-6 anhyd.] | 5、10、25 |
| 446 | Cobalt dodecahydrododecaborate, dihydrate | ||
| 597 | Calcium dodecahydrododecaborate monohydrate | CAS [90157-87-2 anhyd.] | 5、10、25 |
| 492 | Rubidium dodecahydrododecaborate | CAS [12598-46-8] | 5、10、25 |
| 243 | Sodium dodecachlorododecaborate | CAS [111637-82-2] | 5、10、25、100 |
| 244 | Sodium dodecabromododecaborate | CAS [1253735-09-9] | 5、10、25、100 |
| 550 | Sodium dodecaiodododecaborate | CAS [149211-37-0] | 5、10、25、100 |
| 544 | Sodium hydroxydodecaborate | CAS [56189-13-0] | 1、5、10 |
| 347 | Cesium dodecahydroxydodecaborate | CAS [12589-26-3] | 1、5、10、50 |
| 211 | Sodium mercaptododecaborate, N-BSH | CAS [144885-51-8] | 1、5、10、25、50 |
| 266 | Cesium mercaptododecaborate, N-BSH | CAS [12448-23-6] | 1、5、10、25、50 |
| 587 | Tetramethylammonium mercaptododecaborate, N-BSH | CAS [135274-62-3] | 1、5、10、25、50 |
| 489 | syn -Octadecaborane(22) | CAS No. [21107-45-9] | 1、5、10 |
| 488 | anti -Octadecaborane(22) | CAS No. [21107-56-2] | 1、5、10 |
| 359 | Mixture of syn - and anti -octadecaboranes(22) | 1、5、10、20 | |
| 414 | Triethylammonium decahydrodecaborate 10B | ||
| 556 | Sodium decahydrodecaborate 10B, GB-10 | CAS [12373-10-3] | 1、5、10、25 |
| 258 | Triethylammonium dodecahydrododecaborate 10B | 1、10、25、50 | |
| 226 | Sodium dodecahydrododecaborate 10B | CAS [109851-98-1] | 1、10、25、50 |
| 588 | Cesium dodecahydrododecaborate 10B | CAS [109788-95-6] | 1、10、25、50 |
| 500 | Lithium dodecahydrododecaborate 10B, tetrahydrate | CAS [51745-90-5 anhyd.] | 1、10、25、50 |
| 210 | Sodium mercaptododecaborate 10B, BSH | CAS [12448-24-7] | 1、5、10、50 |
| 603 | Tetramethylammonium mercaptododecaborate 10B | CAS [130207-66-8] | 1、5、10、50 |
| 401 | Cesium mercaptododecaborate 10B | CAS [109742-44-1] | 1、5、10、50 |
| 486 | Triethylammonium dodecahydrododecaborate 11B | 1、10、25、50 | |
| 491 | Sodium dodecahydrododecaborate 11B | 1、5、10 | |
| 466 | Cesium dodecahydrododecaborate 11B | CAS [1347742-49-7] | 1、5、10 |
| 485 | Rubidium dodecahydrododecaborate 11B | CAS [1347742-48-6] | 1、2、5、10 |
| 450 | Sodium mercaptododecaborate 11B | CAS [459142-76-8] | 1、5、10 |
| 457 | Cesium carbaundecaborate | CAS [51391-30-1] | 1、5、10、25、50、100、250 |
| 456 | 7-Amino-7-carbaundecaborate | CAS [12373-10-3] | 1、5、10、25、50、100 |
| 264 | 7-Trimethylamino-7-carbaundecaborate | CAS [31117-16-5] | 1、5、10、25、50、100、250 |
| 676 | Sodium carbaundecaborate | CAS [68084-95-7] | 1、5、10 |
| 677 | Lithium carbaundecaborate, hemihydrate | CAS [2169943-32-0] | 1、5、10 |
| 251 | 1-Amino-1-carbadodecaborate | CAS [749831-19-4] | 1、5 |
| 252 | 1-Trimethylamine-1-carbadodecaborane | CAS [92468-34-3] | 1、5 |
| 212 | Trimethylammonium carbadodecaborate | CAS No.[108608-25-9] | 1、5、10、20、50 |
| 213 | Cesium carbadodecaborate | CAS No.[12539-26-3] | 1、5、10、20、50 |
| 421 | Triethylammonium carbadodecaborate | CAS No.[223548-06-9] | 1、5、10、20、50 |
| 242 | Potassium carbadodecaborate | CAS No.[92468-39-8] | 1、5、10、20、50 |
| 647 | Sodium carbadodecaborate | CAS No.[92468-38-7] | 1、5、10、20、50 |
| 648 | Lithium carbadodecaborate hemihydrate | CAS No.[92468-37-6 anhyd.] | 1、5、10、20、50 |
| 813 | Calcium carbadodecaborate trihydrate | CAS No.[2077150-90-2 anhyd.] | 1、5、10、20、50 |
| 523 | Cesium 1-methyl-1-carbadodecaborate new | CAS No.[176099-40-4] | 1、5、10 |
| 349 | Trimethylammonium 1-propyl-1-carbadodecaborate new | 1、5、10 | |
| 351 | Trimethylammonium 1-mercapto-1-carbadodecaborate new | 1、5、10 | |
| 365 | Trimethylammonium 1-hydroxy-1-carbadodecaborate new | CAS No.[2077207-91-9] | 1、5、10 |
| 366 | Trimethylammonium 1-carboxy-1-carbadodecaborate new | CAS No.[1252604-78-6] | 1、5、10 |
| 378 | Cesium closo -1-carbadecaborate | CAS No.[12539-20-7] | 1、5、10 |
| 649 | Sodium closo -1-carbadecaborate | CAS No.[94322-26-6] | 1、5、10 |
| 650 | Lithium closo -1-carbadecaborate, hydrate | CAS No.[94322-25-5 anhyd.] | 1、5、10 |
| 814 | Calcium closo -1-carbadecaborate, dihydrate | 1、5、10 | |
| 412 | Trimethylammonium 7,8-dicarbaundecaborate | CAS No.[12543-22-5] | 1、5、10、25、50、100 |
| 613 | Cesium 7,8-dicarbaundecaborate | CAS No.[63748-65-2] | 1、5、10、25、50、100 |
| 673 | Sodium 7,8-dicarbaundecaborate | CAS No.[12602-34-5] | 1、5、10、25、50、100 |
| 682 | Lithium 7,8-dicarbaundecaborate dihydrate | CAS No.[1629094-87-6 anhyd.] | 1、5、10、25、50、100 |
| 214 | Trimethylammonium 7-methyl-7,8-dicarbaundecaborate | 1、5、10、25、50 | |
| 495 | Trimethylammonium 7,9-dicarbaundecaborate | CAS No.[54531-56-5] | 1、5、10、25、50、100 |
| 384 | Cesium 7,9-dicarbaundecaborate | CAS No.[12305-33-8] | 1、5、10、25、50、100 |
| 674 | Sodium 7,9-dicarbaundecaborate | 1、5、10、25、50、100 | |
| 683 | Lithium 7,9-dicarbaundecaborate trihydrate | CAS No.[1629094-86-5 anhyd.] | 1、5、10、25、50、100 |
| 208 | Decaborane(14) | CAS [17702-41-9] | 1、5、10、25、50、100、250 |
| 419 | Bis(acetonitrile)-decabora | CAS [28377-97-1] | 5、20、100、250 |
| 238 | Bis(dimethylsulfide)-decaborane | CAS [28377-92-6] | 5、20、100、250 |
| 204 | Decaborane(14) 10B(Isotopic enrichment: 10B >99.5%) | CAS [488806-75-3] | 1、5、10、25 |
| 301 | Decaborane(14) 11B(Isotopic enrichment: 11B >99.8%) | CAS [94601-45-3] | 1、5、10、25 |
| 199 | o -Carborane | CAS No. [16872-09-6] | 1、5、10、25、50、100、250、500 |
| 209 | 1-Methyl-o -carborane | CAS No. [16872-10-9] | 5、10、25、50、100 |
| 233 | 1-Bromomethyl-o -carborane | CAS No. [19496-84-5] | 5、10、25、50、100 |
| 269 | 1,2-Dimethyl-o -carborane | CAS No. [17032-21-2] | 1、5、10 |
| 332 | 1-n-Propyl-o -carborane | CAS No. [23940-16-1] | 1、5、10 |
| 463 | 1-Hexyl-o -carborane | CAS No. [20740-05-0] | 1、5、10、25、50、100 |
| 464 | 1,2-Dihexyl-o -carborane | CAS No. [280762-92-7] | 1、5、10、25、50 |
| 203 | 1-Phenyl-o -carborane | CAS No. [16390-61-7] | 1、5、10、25、50、100 |
| 465 | 1,2-Didodecyl-o -carboran | CAS No. [943026-62-8] | 1、5、10、25、50 |
| 609 | 1-Methyl-2-propargyl-o -carborane | CAS No. [23868-57-7] | 1、2、5 |
| 318 | 1-Hydroxymetyl-o -carborane | CAS No. [19610-34-5] | 1、5、10 |
| 448 | 1,2-Bis(hydroxymethyl)-o -carborane | CAS No. [19610-37-8] | 1、5、10 |
| 297 | o -Carborane-1-carboxylic acid | CAS No. [18178-04-6] | 1、5、10 |
| 253 | o -Carborane-1,2-dicarboxylic acid | CAS No. [23835-80-5] | 1、5、10 |
| 480 | 1-Trimethylsilyl-o -carborane | CAS No. [18971-67-0] | 1、5、10、25 |
| 516 | 1-Hydroxy-o -carborane | CAS No. [23987-99-7] | 1、2、5、10 |
| 502 | 1,2-Dihydroxy-o -carboran | CAS No. [868382-62-1] | 1、2、5、10 |
| 293 | 1-Mercapto-o -carborane | CAS No. [17526-07-7] | 1、5、10、25 |
| 232 | 1,2-Dimercapto-o -carbora | CAS No. [23810-63-1] | 1、5、10、25 |
| 345 | 9-Iodo-o -carborane | CAS No. [17830-03-4] | 5、10、20 |
| 346 | 9,12-Diiodo-o -carborane | CAS No. [17702-35-1] | 5、10、20 |
| 240 | 9-Mercapto-o -carborane | CAS No. [64493-43-2] | 1、5、10 |
| 433 | 9,12-Dimercapto-o -carborane | CAS No. [75572-47-3] | 1、2、5 |
| 440 | 8,9,12-Trimercapto-o -carborane | CAS No. [1423066-18-5] | 1、2、5 |
| 200 | m -Carborane | CAS No. [16986-24-6] | 1、5、10、25、50、100、250 |
| 518 | 1-Methyl-m -carborane | CAS No. [17378-55-1] | 1、5、10、25 |
| 317 | 1-Allyl-7-methyl-m -carbor | CAS No. [20670-09-1] | 1、5、10、25 |
| 319 | 1,7-Diallyl-m -carborane | CAS No. [1232168-57-8] | 1、5、10、25 |
| 320 | 1,7-Bis(hydroxymethyl)-m -carborane | CAS No. [23924-78-9] | 1、5、10、50 |
| 298 | m -Carborane-1-carboxylic acid | CAS No. [18581-81-2] | 1、5、10 |
| 261 | 1,7-Bis(chlordimethylsilyl)-m -carborane | CAS No. [16996-48-8] | 1、5、10、50、100、250 |
| 259 | 1,7-Bis(methoxydimethylsilyl)-m -carborane | CAS No. [17631-41-3] | 1、5、10、50、100、250 |
| 321 | 1,7-Bis(hydroxydimethylsilyl)-m -carborane | CAS No. [22742-19-4] | 1、5、10、50、100、250 |
| 481 | 1-Vinyldimethylsilyl-m -carborane | 1、5、10、25 | |
| 501 | 1,7-Bis(vinyltetramethyldisiloxy)-m -carborane | CAS No. [210707-88-3] | 1、5、10、25、50 |
| 527 | 1-Hydroxy-m -carborane | CAS No. [23988-02-5] | 1、5、10 |
| 532 | 1,7-Dihydroxy-m -carbora | CAS No. [55629-26-0] | 1、5、10 |
| 496 | 1-Mercapto-m -carborane | CAS No. [56310-80-6] | 1、2、5、10 |
| 434 | 1,7-Dimercapto-m -carborane | CAS No. [23810-64-2] | 1、2、5、10 |
| 513 | 9-Mercapto-m -carborane | CAS No. [64493-44-3] | 1、2、5、10 |
| 201 | p -Carborane | CAS No. [20644-12-6] | 1、5、10、25、50 |
| 267 | p -Carborane-1,12-dicarboxylic acid | CAS No. [23087-99-2] | 1、5、10 |
| 528 | 1-Hydroxy-p -carborane | CAS No. [54360-43-9] | 1、5、10 |
| 533 | 1,12-Dihydroxy-p -carbora | CAS No. [55629-27-1] | 1、5、10 |
| 497 | 1-Mercapto-p -carborane | CAS No. [69985-41-7] | 1、2、5、10 |
| 498 | 1,12-Dimercapto-p -carborane | CAS No. [24228-77-1] | 1、2、5、10 |
| 341 | 4,5-Dicarba-arachno -nonaborane(13) new | CAS No. [113678-30-1] | 5、10、25 |
| 339 | 4,6-Dicarba-arachno -nonaborane(13) new | CAS No. [17653-38-2] | 5、10、25 |
| 340 | 6,9-Dicarba-arachno -decaborane(14) new | 5、10、25 | |
| 227 | 5,6-Dicarba-nido -decaborane(12) | CAS No. [41655-26-9] | 5、10、20 |
| 539 | Ten-vertex-o -carborane | CAS No. [41655-27-0] | 2、5 |
| 354 | Ten-vertex-m -carborane | CAS No. [23704-81-6] | 2、5 |
| 255 | Ten-vertex-p -carborane | CAS No. [23653-12-6] | 2、5 |
| 206 | o -Carborane 10B | CAS No. [760207-79-2] | 1、5、10 |
| 207 | 1-Methyl-o -carborane 10B | CAS No. [1177403-84-7] | 1、5、10 |
| 205 | m -Carborane 10B | 1、5、10 | |
| 595 | o -Carborane 11B | CAS No. [1291083-31-2] | 1、5、10 |
| 407 | m -Carborane 11B | CAS No. [1291083-36-7] | 1、5、10 |
| 271 | COSAN | CAS No.[60146-18-1] | 1、5、10、25、50、100、250 |
| 218 | Chloro-protected cesium bis(1,2-dicarbollide)-cobaltate | CAS No.[84913-29-1] | 1、5、10、25、50、100、250 |
| 393 | Bromo-protected cesium bis(1,2-dicarbollide)-cobaltate | CAS No.[84933-24-4] | 1、5、10、50 |
| 292 | COSAN dioxanate | CAS No.[188478-29-7] | 1、2、5、10、50 |
| 476 | NISAN | CAS No.[36548-55-7] | 1、5、10、25、50 |
| 483 | FESAN | CAS No.[12304-97-1] | 1、5、10、25、50 |
| 520 | Lithium COSAN | CAS No.[167568-99-2] | 1、5 |
| 517 | Sodium COSAN | CAS No.[99492-72-5] | 1、5 |
| 392 | Sodium borohydride | CAS [16940-66-2] | 50、100、250、500、1000 |
| 429 | Rubidium borohydride | CAS [20346-99-0] | 1、2、5、10 |
| 225 | Cesium borohydride | CAS [19193-36-3] | 1、2、5、10 |
| 596 | Calcium borohydride | CAS [17068-95-0] | 1、5、10、25 |
| 636 | Magnesium borohydride | CAS [16903-37-0] | 1、5、10、25 |
| 263 | Lithium borodeuteride | CAS [15246-28-3] | 1、2、5、10 |
| 361 | Lithium borohydride 10B | 1、2、5、10 | |
| 362 | Lithium borodeuteride 10B | 1、2、5、10 | |
| 323 | Lithium borohydride 11B | 1、2、5、10 | |
| 239 | Lithium borodeuteride 11B | CAS [1242073-72-8] | 1、2、5、10 |
| 363 | Lithium borohydride 7Li | 1、2、5、10 | |
| 367 | Lithium borodeuteride 7Li | 1、2、5、10 | |
| 370 | Lithium borohydride 7Li, 10B | CAS [139980-21-5] | 1、2、5、10 |
| 371 | Lithium borodeuteride 7Li, 10B | CAS [163779-14-4] | 1、2、5、10 |
| 442 | Lithium borohydride 7Li, 11B | CAS [139980-20-4] | 2、5 |
| 499 | Lithium borodeuteride 7Li,11B | CAS [163779-13-3] | 1、2、5、10 |
| 326 | Sodium borodeuteride | CAS [15681-89-7] | 5、10 |
| 202 | Sodium borohyride 10B | CAS [72901-47-4] | 1、2、5、10 |
| 373 | Sodium borodeuteride 10B | CAS [163779-18-8] | 1、2、5、10 |
| 396 | Sodium borohyride 11B | CAS [72901-46-3] | 1、2、5、10 |
| 397 | Sodium borodeuteride 11B | CAS [163779-17-7] | 1、2、5、10 |
| 379 | Potassium borodeuteride | CAS [17440-13-0] | 5、10 |
| 455 | Potassium borohyride 10B | 1、2、5、10 | |
| 417 | Potassium borodeuteride 10B | 1、2、5、10 | |
| 447 | Potassium borohyride 11B | CAS [1417734-35-0] | 1、2、5、10 |
| 413 | Potassium borodeuteride 11B | 1、2、5、10 | |
| 508 | Calcium borodeuteride | CAS [122042-59-5] | 1、2、5、10 |
| 352 | Calcium borohydride 10B | 1、2、5、10 | |
| 355 | Calcium borohydride 11B | 1、2、5、10 | |
| 220 | Calcium borodeuteride 11B | CAS [1309461-44-6] | 1、2、5、10 |
| 656 | Magnesium borohydride 11B | 1、2、5、10 | |
| 452 | Cesium borohydride 11B | CAS [1417734-38-3] | 1、2、5、10 |
| 504 | Cesium borodeuteride 11B | 1、2、5、10 | |
| 462 | Rubidium borohydride 11B | CAS [1417734-37-2] | 1、2、5、10 |
| 505 | Rubidium borodeuteride 11B | CAS [1445366-23-3] | 1、2、5、10 |
| 300 | Dimethylamine borane complex, DMAB | CAS [74-94-2] | 10、25、100、250、1000 |
| 415 | Ammonia borane complex | CAS [13774-81-7] | 10、20、50、100 |
| 415,1 | Ammonia borane complex +90% (purity >90%) | CAS [13774-81-7] | 10、20、50、100、200、500、1000 |
| 294 | Triethylamine borane complex | CAS [1722-26-5] | 10、50、100、500 |
| 221 | Dimethylsulfide borane complex, 10M solution in Me2S (d=0.8g/ml 26°C) | CAS [13292-87-0] | 100、800 |
| 375 | Ammonia borane complex 10B | CAS [77074-21-6] | 1、5、10 |
| 468 | Ammonia borane complex 11B | CAS [77069-36-4] | 1、5、10 |
| 563 | Deuteroammonia deuteroborane complex 11B | CAS [933675-78-6] | 1、2、5 |
| 577 | Deuteroammonia deuteroborane complex | CAS [20214-17-9] | 1、2、5 |
| 435 | Triethylamine deuteroborane complex | CAS [4680-65-3] | 10、25、50、100 |
| 311 | Triethylamine borane complex 10B | CAS [115959-96-1] | 10、25、50、100 |
| 449 | Triethylamine deuteroborane complex 10B | 10、25、50、100 | |
| 430 | Triethylamine borane complex 11B | 10、25、50、100 | |
| 411 | Triethylamine deuteroborane complex 11B | 10、25、50、100 | |
| 477 | Dimethylsulfide deuteroborane complex (purity > 95%) | CAS [117981-99-4] | 10、25、50、100 |
| 254 | Dimethylsulfide borane complex 10B(purity > 95%) | 10、25、50、100 | |
| 471 | Dimethylsulfide deuteroborane complex 10B(purity > 95%) | 10、25、50、100 | |
| 594 | Dimethylsulfide borane complex 11B(purity > 95%) | 10、25、50、100 | |
| 473 | Dimethylsulfide deuteroborane complex 11B(purity > 95%) | CAS [2230877-77-5] | 10、25、50、100 |
| 219 | 4-Borono-L-phenylalanine, L-BPA | CAS [76410-58-7] | 1、5、10、50 |
| 541 | Trimethylborate | CAS [121-43-7] | 5、10、50、100、400、800 |
| 268 | 4-Borono-L-phenylalanine 10B, BPA (also provide BPA produced by GMP.) | CAS [80994-59-8] | 1、10、50 |
| 436 | Trimethylborate 10B | CAS [4832-27-3] | 5、10、50、100、400、800 |
| 262 | Tri-n-butylborate 10B | CAS [207742-80-1] | 10、50、100、400、800 |
| 344 | Triphenylborate 10B | 10、50、100、400 | |
| 409 | Trimethylborate 11B | CAS [3349-42-6] | 3、10、25、50 |
| 423 | Tri-n-butylborate 11B | CAS [207742-78-7] | 10、25、50、100 |
| 431 | Triphenylborate 11B | 10、25、50、100 | |
| 210 | Sodium mercaptododecaborate 10B, BSH | CAS [12448-24-7] | 1、5、10、50 |
| 268 | 4-Borono-L-phenylalanine 10B, BPA ( also provide BPA produced by GMP.) | CAS [80994-59-8] | 1、10、50 |
| 556 | Sodium decahydrodecaborate 10B, GB-10 | CAS [666747-96-2] | 1、5、10、25 |
| 230 | TODGA | CAS [342794-43-8] | 5、10、20、50、100 |
| 296 | DIHOCA dihexyloctanoyl amide | CAS [75397-93-2] | 5、10、20、50、100 |
| 611 | TEHDGA | CAS [669087-46-1] | 5、10、20、50、100 |
| 348 | 7Li-Lithium bromide | CAS [34007-72-2] | 5、10、20、50、100 |
| 553 | 7Li-Lithium iodide | CAS [29911-74-8] | 5、10、20 |
| 308 | 7Li-Lithium chloride | CAS [20233-17-4] | 5、10、20 |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技授权代理Katchem全系列硼化学产品"> 艾美捷科技授权代理Katchem全系列硼化学产品
Repligen是一家致力于开发和生产用于生物制药的材料的美国公司。
Repligen is a bioprocessing-focused life sciences company bringing over 35 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs, principally monoclonal antibodies.
Repligen公司的主要产品：
（1）UPSTREAM SOLUTIONS
XCell™ ATF System
Spectrum Filtration
Cell Culture Supplements
（2）DOWNSTREAM SOLUTIONS
OPUS® Pre-packed Chromatography Columns
Spectrum Filtration
TangenX™ TFF Cassettes
Protein A Affinity Resins
Protein A Ligands
（3）ANALYTICS
ELISA Kits
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Repligen"> Repligen
艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.
Berry & Associates的主要产品包括：
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸
Dendritics公司主要关注人类树突状细胞，希望找到能够促使CD34+造血前体细胞转化为树突状细胞（在GM-CSF和TNF-alpha存在的情况下）的细胞因子。在1992-2005年间，大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。
DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California.
Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha.
The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs.
<<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Dendritics"> Dendritics
Alamanda Polymers是世界领先的多聚氨基酸生产商，其主要产品为多聚寡氨基酸链以及PEG化的多聚氨基酸链。其拥有独特的多聚化工艺，是唯一能够提供确切的聚合数值多聚氨基酸的公司，能够使研究者的实验结果更加具有可重复性。
Alamanda Polymers specializes in the manufacturing of well-defined polyamino acids for research laboratories doing work in gene therapy, encapsulation, drug delivery, cell adhesion, and surface coating. Our company provides a wide range of metal-free biopolymers including homopolyamino acids and PEGylated polyamino acids. Due to our characteristic polymerization process, we are the only supplier able to offer effectually exact polyamino acid chain lengths thereby giving researchers new options for use and consistently reproducible results.
Alamanda Polymer has more than 15 years experience in the synthesis of polyamino acids, has developed a polymerization process that enables them to have complete control over the molecular weight of our polyamino acids without the use of metal catalysts. Furthermore, not only does the process enable us to achieve effectually exact chain lengths but also highly monomodal products (polydispersity index: 1.01-1.2) and batch-to-batch consistency.
产品包括：
Side-Functionalized Homopolyamino Acids
Poly-L-lysine
Poly-L-glutamic acid
End-Functionalized Homopolyamino Acids
Poly-L-lysine
Poly-L-glutamic acid
Poly-L-arginine
Homopolyamino Acids
Poly-L-lysine
Poly-D-lysine
Poly-D,L-lysine
Poly-L-ornithine
Poly-L-homoarginine
Poly-L-arginine
Poly-L-glutamic acid
Poly-D-glutamic acid
Poly-D,L-glutamic acid
Poly-L-aspartic acid
PEGylated Polyamino Acids
PEG-b-poly-L-lysine
N3-PEG-b-poly-L-lysine
PEG-b-poly-L-glutamic acid
N3-PEG-b-poly-L-glutamic acid
PEG-b-poly-L-aspartic acid
Poly(L-Lys)-b-PEG-b-poly(L-Lys)
Poly(L-Glu)-b-PEG-b-poly(L-Glu)
Poly(L-Asp)-b-PEG-b-poly(L-Asp)
Custom Polyamino Acids
Poly-L-lysine
Poly-D-lysine
Poly-L-glutamic acid
Poly-D,L-glutamic acid
Poly-L-arginine
PEG-b-poly-L-lysine
PEG-b-poly-D-lysine
PEG-b-poly-L-glutamic acid
PEG-b-poly-L-aspartic acid
Poly(L-Glu)-b-PEG-b-poly(L-Glu)
Polyamino Acids For Cell Culture
Poly-L-lysine
Poly-D-lysine
Poly-L-ornithine
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Alamanda Polymers"> Alamanda Polymers地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：15172431432
传真：13212737804
邮箱：sales@amyjet.com
0.3474
